Defining the Role of Adjuvant Therapy: Cholangiocarcinoma and Gall Bla

Discussion Board › Forums › New Developments › Defining the Role of Adjuvant Therapy: Cholangiocarcinoma and Gall Bla

Viewing 5 posts - 1 through 5 (of 5 total)
  • Author
    Posts
  • April 26, 2014 at 11:16 pm #80894
    marions
    Moderator

    Julie…the UK study (Xeloda vs. no treatment) in an adjuvant setting is one we are expecting to receive the data from within this year. All others are a couple years out. What makes me think though, Julie, is based on the fact that numerous, adjuvant studies are conducted, that there is a suspicion that it may be of benefit to the patient.
    Hugs,
    Marion

    April 26, 2014 at 10:11 pm #80893
    iowagirl
    Member

    Marion, do you have any info on when the results of one or more of the studies will be released on adjuvant therapy following surgery?

    Julie T.

    March 20, 2014 at 1:12 pm #80892
    gavin
    Moderator

    Looking forward to reading that data Marion.

    March 19, 2014 at 6:46 pm #80891
    marions
    Moderator

    As mentioned previously, within a few months we will be able to see some data from adjuvant clinical trials conducted.

    March 19, 2014 at 6:28 pm #9681
    gavin
    Moderator

    Defining the Role of Adjuvant Therapy: Cholangiocarcinoma and Gall Bladder Cancer.

    http://www.ncbi.nlm.nih.gov/pubmed/24635866

  • Author
    Posts
Viewing 5 posts - 1 through 5 (of 5 total)
  • The forum ‘New Developments’ is closed to new topics and replies.